Allergy-Immunology
Cardiology
Endocrinology
Gastroenterology
General Internal Medicine
Geriatric Medicine
Hematology / Oncology
Hepatology
Hospital Medicine
Immunotherapy
Infectious Diseases
Nephrology / Hypertension
Pulmonary & Critical Care
Rheumatology
Sports Medicine

Mark E. Molitch, MD

Professor of Medicine
Director, Endocrinology Clinic

Medical School
University of Pennsylvania, Philadelphia, PA

Residency
Hospital of the University of Pennsylvania, Philadelphia, PA

Endocrine Fellowships
Harbor General Hospital, University of California, Los Angeles (UCLA), CA

Board Certified
American Board of Internal Medicine 1972;
Endocrinology and Metabolism 1975

Dr. Molitch performs clinical research in the fields of pituitary hormone regulation, pathogenesis and treatment of pituitary tumors, and diabetes complications. His research is conducted primarily in the Clinical Research Center.

Research Topics

  • Development of new treatments for pituitary tumors
  • Pathogenesis of prolactin and growth hormone secreting pituitary tumors
  • Prevention and treatment of the long-term complications of diabetes mellitus

Selected Publications

  • Gillam MP, Middler S, Freed DJ, Molitch ME 2002 The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. J Clin Endocrinol Metab 87:4447-4451
  • Diabetes Prevention Program Research Group:  Reduction in the incidence of Type 2 Diabetes with lifestyle intervention or metformin.  N Engl J Med 2002;346-393-403.
  • Molitch ME 2002 Editorial:  Diagnosis of GH deficiency in adults - how good do the criteria need to be? J Clin Endocrinol Metab 87:473-6
  • Molitch ME 2001 Neuroendocrinology. In Endocrinology and Metabolism, 4th Edition. Felig P, Frohman LA (eds.). McGraw-Hill Book Co., New York, 111-171
  • Thomas W, Shen Y, Molitch ME, Steffes MW 2001 Rise in albuminuria and blood pressure in patients who progressed to diabetic nephropathy in the Diabetes Control and Complications Trial. J Am Soc Nephrol 12:333-40
  • Oates SK, Roth SI, Molitch ME 2000 Corticotropin-releasing hormone producing medullary thyroid carcinoma causing Cushing's syndrome: clinical and pathological findings.  Endocrine Pathology 2000; 11:277-285.
  • Epidemiology of Diabetes Interventions and Complications (EDIC)/Diabetes Control and Complications Trial (DCCT) Study Group 2000 Retinopathy and nephropathy in patients with Type 1 Diabetes four years after a trial of intensive therapy.  N Engl J Med 2000; 342:381-389.